Abstract:ATP-sensitive potassium (K(ATP)) channels are widely distributed in vasculatures, and play an important role in the vascular tone regulation. The K(ATP) channels consist of 4 pore-forming inward rectifier K(+) channel (Kir) subunits and 4 regulatory sulfonylurea receptors (SUR). The major vascular isoform of K(ATP) channels is composed of Kir6.1/SUR2B, although low levels of other subunits are also present in vascular beds. The observation from transgenic mice and humans carrying Kir6.1/SUR2B channel mutations strongly supports that normal activity of the Kir6.1/SUR2B channel is critical for cardiovascular function. The Kir6.1/SUR2B channel is regulated by intracellular ATP and ADP. The channel is a common target of several vasodilators and vasoconstrictors. Endogenous vasopressors such as arginine vasopressin and α-adrenoceptor agonists stimulate protein kinase C (PKC) and inhibit the K(ATP) channels, while vasodilators such as β-adrenoceptor agonists and vasoactive intestinal polypeptide increase K(ATP) channel activity by activating the adenylate cyclase-cAMP-protein kinase A (PKA) pathway. PKC phosphorylates a cluster of 4 serine residues at C-terminus of Kir6.1, whereas PKA acts on Ser1387 in the nucleotide binding domain 2 of SUR2B. The Kir6.1/SUR2B channel is also inhibited by oxidants including reactive oxygen species allowing vascular regulation in oxidative stress. The molecular basis underlying such a channel inhibition is likely to be mediated by S-glutathionylation at a few cysteine residues, especially Cys176, in Kir6.1. Furthermore, the channel activity is augmented in endotoxemia or septic shock, as a result of the upregulation of Kir6.1/SUR2B expression. Activation of the nuclear factor-κB dependent transcriptional mechanism contributes to the Kir6.1/SUR2B channel upregulation by lipopolysaccharides and perhaps other toll-like receptor ligands as well. In this review, we summarize the vascular K(ATP) channel regulation under physiological and pathophysiological conditions, and discuss the importance of K(ATP) channel as a potentially useful target in the treatment and prevention of cardiovascular diseases.

[Atp-Sensitive Potassium Channel and Its Cardiovascular Protection Effects].

Functional Protection Against Cardiac Diseases Depends On Atp-Sensitive Potassium Channels

Genetic Discovery of ATP-Sensitive K+ Channels in Cardiovascular Diseases.

K(ATP) channel action in vascular tone regulation: from genetics to diseases.

[Mechanisms of Cardioprotection Induced by Preconditioning after Activation of MITOK(ATP) Channel].

The role of KATP channels in cerebral ischemic stroke and diabetes

ATP-sensitive potassium channels and ischemic preconditioning

The Emerging Structural Pharmacology of ATP-Sensitive Potassium Channels

ATP-sensitive Potassium Channels: Novel Potential Roles in Parkinson’s Disease

Recent advances in KATP channel

Identification and characterisation of functional Kir6.1‐containing ATP‐sensitive potassium channels in the cardiac ventricular sarcolemmal membrane

Adenosine Triphosphate-Sensitive Potassium Channels and Cardiomyopathies (Review)

The ATP-sensitive potassium channel: a therapeutic target for neurodegeneration?

ATP-sensitive Potassium Channels and Neuroprotection Study

Structure of a Pancreatic ATP-Sensitive Potassium Channel.

From Cellular Functions to Therapeutic Potentials

Abstract 15729: Subcellular Distribution of ATP-Sensitive K+ Channels in Ventricular Myocytes

Elimination of allosteric modulation of myocardial KATP channels by ATP and protons in two Kir6.2 polymorphisms found in sudden cardiac death.

Effects of P266T mutation on the characteristics of ATP-sensitive potassium channel

Structural insights into the mechanism of pancreatic KATP channel regulation by nucleotides

ATP-Sensitive Potassium Channel Function During the Progression of Pressure Overload Heart Failure in Rats